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RESEARCH ARTICLE
BMP- and neuropilin 1-mediated motor axon navigation relies
on spastin alternative translation
Nicolas Jardin1, François Giudicelli2, Daniel Ten Martıń1, Anaïs Vitrac1, Stéphanie De Gois1, Rachel Allison3,
Corinne Houart4, Evan Reid3, Jamilé Hazan1,* and Coralie Fassier1,*
ABSTRACT
Functional analyses of genes responsible for neurodegenerative
disorders have unveiled crucial links between neurodegenerative
processes and key developmental signalling pathways. Mutations in
SPG4-encoding spastin cause hereditary spastic paraplegia (HSP).
Spastin is involved in diverse cellular processes that couple
microtubule severing to membrane remodelling. Two main spastin
isoforms are synthesised from alternative translational start sites
(M1 and M87). However, their specific roles in neuronal development
and homeostasis remain largely unknown. To selectively unravel their
neuronal function, we blocked spastin synthesis from each initiation
codon during zebrafish development and performed rescue analyses.
The knockdown of each isoform led to different motor neuron and
locomotion defects, which were not rescued by the selective
expression of the other isoform. Notably, both morphant neuronal
phenotypes were observed in a CRISPR/Cas9 spastin mutant. We
next showed that M1 spastin, together with HSP proteins atlastin 1
and NIPA1, drives motor axon targeting by repressing BMP signalling,
whereas M87 spastin acts downstream of neuropilin 1 to control motor
neuron migration. Our data therefore suggest that defective BMP and
neuropilin 1 signalling may contribute to the motor phenotype in a
vertebrate model of spastin depletion.
KEY WORDS: Axon navigation, BMP signalling,
Hereditary spastic paraplegia, Neuropilin 1, Spastin, Zebrafish
INTRODUCTION
Various neurodegenerative disorders have been shown to result from
the primary failure of selectively vulnerable neurons during embryonic
and postnatal development of the nervous system. Indeed, proteins
implicated in early- and late-onset neurodegeneration are massively
expressed throughout embryogenesis and frequently impact on
different steps of neural development, such as neuronal proliferation,
differentiation and migration, axon targeting or synaptogenesis.
Furthermore, these affected molecular bases underlying belated
neurodegenerative processes are often embedded into key
developmental signalling pathways in both invertebrate and
vertebrate pathogenic models, such as the Notch (Levitan and
Greenwald, 1995) and Wnt (Nishimura et al., 1999) pathways in
Alzheimer’s disease, Wnt signalling in Huntington disease
(Dupont et al., 2012; Tourette et al., 2014) or the bone
morphogenetic protein (BMP) pathway in motor neurodegeneration
(Wang et al., 2007; Chang et al., 2008; Ratnaparkhi et al., 2008;
Fassier et al., 2010; Nahm et al., 2013).
Hereditary spastic paraplegia (HSP) is a heterogeneous group of
neurological disorders mainly characterised by progressive spasticity
of the lower limbs due to the degeneration of the cortico-spinal tracts.
HSP shows an extreme genetic heterogeneity with more than 84
spastic paraplegia gene (SPG) loci reported so far (Tesson et al.,
2015). Mutations in the SPG4 gene encoding the multifaceted
microtubule-severing spastin cause the major form of autosomal
dominant HSP (Hazan et al., 1999). More than 200 mutations have
been described within SPG4 and the vast majority of them are likely
to act via haploinsufficiency (Fonknechten et al., 2000; Roll-Mecak
and Vale, 2008; Riano et al., 2009). Spastin is essential for numerous
cellular processes (Connell et al., 2009; Park et al., 2010; Allison
et al., 2013, 2017; Papadopoulos et al., 2015; Vietri et al., 2015)
linking microtubule (MT) severing to membrane remodelling
(Blackstone et al., 2011; Lumb et al., 2012). In developing neurons,
spastin is required for axonal and synaptic growth (Sherwood et al.,
2004; Trotta et al., 2004;Wood et al., 2006; Riano et al., 2009) as well
as neurite branching or pruning (Yu et al., 2008; Brill et al., 2016),
whereas in mature neurons it preserves axonal maintenance and
transport homeostasis (Tarrade et al., 2006; Fassier et al., 2013;
Denton et al., 2014; Havlicek et al., 2014). Notably, alternative
translation of mammalian SPG4 transcript directs the synthesis of two
main spastin isoforms (M1 andM87 isoforms; Claudiani et al., 2005),
which show different structural domains, tissue and subcellular
distribution, as well as binding partners (Evans et al., 2006; Sanderson
et al., 2006; Connell et al., 2009; Park et al., 2010; Solowska et al.,
2010; Montenegro et al., 2012; Papadopoulos et al., 2015). However,
although spastin function has been intensively investigated, most
functional studies were performed in non-neuronal cell lines and
failed to address the roles of these spastin isoforms in vivo and their
respective contribution to HSP pathogenesis. A few arguments
suggested amajor involvement of theM1 isoform: it is enriched in the
developing and adult spinal cord (Claudiani et al., 2005; Solowska
et al., 2010), the overexpression of its pathogenic forms have toxic
effects compared with that of M87 (Solowska et al., 2008, 2014; Leo
et al., 2017), and it selectively binds to other known HSP proteins
(Evans et al., 2006; Sanderson et al., 2006; Park et al., 2010;
Montenegro et al., 2012), including the BMP inhibitor atlastin 1
(Fassier et al., 2010; Zhao and Hedera, 2013), which suggested a
specific role for this long isoform in the BMP pathway (which is
known to be dysregulated in different subtypes of HSP) (Wang et al.,Received 21 December 2017; Accepted 16 July 2018
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2007; Tsang et al., 2009; Fassier et al., 2010; Renvoisé et al., 2012;
Nahm et al., 2013; Song et al., 2013; Mao et al., 2015).
Here, loss-of-function and rescue analyses during zebrafish
embryogenesis allowed us to reveal that spastin isoforms show
non-overlapping key functions in spinal motor neuron development
and larval locomotion, whereas their specific involvement in the
BMP or the neuropilin 1 axon guidance pathway was unravelled.
RESULTS
Zebrafish spastin transcript drives the synthesis of two
spastin isoforms with distinct subcellular distribution in
developing motor neurons
All published spastin knockdown experiments in the zebrafish have
been performed with antisense morpholino oligonucleotides
targeted against the first ATG (Wood et al., 2006; Butler et al.,
2010; Allison et al., 2013). Yet the presence of a second in-frame
ATG (encoding methionine 61 and corresponding to human M87)
in the teleost sequence has been reported (Wood et al., 2006; Fig. 1A).
To assesswhether alternative translation of zebrafish spastin transcript
drives the synthesis of two main isoforms as in mammals, we cloned
the HA-tagged version of zebrafish spastin cDNA, including the
5′ untranslated region (UTR) that has been shown to influence the
expression ratio of the two isoforms (Claudiani et al., 2005), in an
expression vector (pCS2+DrSp-HA). We also performed targeted
mutagenesis of each ATG (pCS2+DrSp-HAMutATG1; pCS2+DrSp-
HAMutATG2; Fig. 1B) and analysed the expression of wild-type and
MutATG Spastin-HA constructs in transfected COS-7 cells. Western
blot analysis of total protein lysates from cells transfected with these
constructs using an HA antibody revealed that these two ATGs are
functional and drive the synthesis of two zebrafish spastin isoforms
(Fig. 1C) of 62 kDa (DrM1) and 55 kDa (DrM61), both showing a
microtubule-severing activity in vitro (Fig. 1D). The expression
ratio of these two spastin isoforms was conserved between
mammals and zebrafish, with the long isoform showing a far
weaker expression, possibly owing to the presence of a poor, but
highly conserved, Kozak sequence surrounding the first ATG
(Fig. 1A,C). In vivo, similar results were obtained from zebrafish
embryos injected with wild-type (DrSpastin-HA) or mutated
(DrM61-HA and DrM1-HA) spastin mRNAs (Fig. 1E), which
indicated that the synthesis of zebrafish spastin occurred through
alternative use of the two initiation codons. As anti-human
spastin86-340 antibody (Connell et al., 2009) recognised
overexpressed DrM1 and DrM61 in COS-7 cells (Fig. 1C),
we used this antibody to assess the endogenous expression of these
two isoforms during zebrafish development. Both isoforms were
expressed at all embryonic stages from 12 to 36 h post-fertilisation
(hpf ). An additional smaller band of 52 kDa was also detected at
all developmental stages (Fig. 1F), most likely corresponding to a
splice variant of the short isoform. Indeed, we observed that:
(1) spastin exon 4 could be alternatively spliced at these embryonic
stages, as previously described in mammals and nematodes
(Fig. 1G; Svenson et al., 2001; Matsushita-Ishiodori et al., 2007);
and (2) this shorter variant was not produced from in vitro transcribed
DrSpastin-HAmRNA, but (3) was equally immunolabelled by the S51
spastin antibody (data not shown; Errico et al., 2004). This splice
variant was the major short isoform from the 18-somite stage onwards
(Fig. 1F).Moreover, the expression ratio between the long and the short
isoforms significantly varied throughout early stages of development,
especially at key time points of spinal motor neuron development
(between 18 somites and 32 hpf). This ratio was mainly influenced by
the marked and reproducible variations in DrM1 expression, which
suggested a tight regulation of the isoform expression during zebrafish
motor neuron development (Fig. 1F). To investigate their subcellular
distribution and overcome the lack of specific antibody against the long
isoform, we generated two transgenic lines expressing HA-tagged
versions of DrM1 or DrM61 under the control of a UAS promoter.
By crossing these transgenic fish with the Tg(mnGFF7) fish (Asakawa
et al., 2008, 2013) that express the transactivator GAL4 in spinal motor
neurons (SMN), we observed that each isoform displayed distinct
subcellular distribution in these neurons (Fig. 1H). DrM1 showed
a punctate distribution within the soma and all along the axon shaft
(arrows, Fig. 1H) with a clear enrichment in the growth cone
(arrowheads, Fig. 1H,I and Fig. S1), whereas DrM61 was diffusely
expressed in the whole neuron and mainly in the cytoplasm.
The knockdownof each spastin isoformdifferentially affects
zebrafish morphology and locomotion behaviour
To unravel the neuronal function of each spastin isoform, we took
advantage of the morpholino-based knockdown strategy, which has
the unique capacity to block protein synthesis from designated
initiation codons without triggering the degradation of targeted
transcripts, unlike RNA-interference approaches (Summerton, 1999).
Morpholinos targeting the first (MOspATG1; Allison et al., 2013)
or the second (MOspATG2) ATG were designed and injected into
two-cell-stage embryos to downregulate DrM1 or DrM61 during
zebrafish development (Fig. 2A). Mismatch (COMOspATG1 and
COMOspATG2; Fig. 2) and scramble morpholinos (MOscr; Fig. 3)
were used as controls. The knockdown efficiency of each spastin
isoform was assessed by western blot analysis using protein extracts
from embryos co-injected with MOspATG1, MOspATG2 or the
corresponding mismatch morpholinos and DrSpastin-HA mRNA,
using an antibody against the HA tag (Fig. 2B). MOspATG2
efficiently decreased DrM61 expression (61% reduction) compared
with COMOspATG2 without affecting DrM1 levels (Fig. 2B,C).
In contrast, MOspATG1 significantly and drastically reduced DrM1
expression (87% reduction) compared with COMOspATG1 but not
DrM61 levels (Fig. 2B,C). Both ATG1 and ATG2 morphants
(i.e. embryos injected with MOspATG1 or MOspATG2, respectively)
failed to hatch from their chorion at larval stages but the two
groups exhibited different morphological and locomotor phenotypes
(Fig. 2D-F). The majority of ATG1 morphants showed a curved-tail
phenotype (arrow, Fig. 2D), whereas all ATG2 morphants displayed
smaller eyes (asterisk, Fig. 2D) and a yolk tube agenesis (arrowhead,
Fig. 2D) compared with COMOspATG1 and COMOspATG2 larvae.
Furthermore, a touch-escape response test at 72 hpf showed that
both morphants displayed obvious locomotion defects, which were
characterised by reduced swimming speed and covered distances
compared with their related control larvae, and appeared to be
more severe for ATG2 than for ATG1 morphants (Fig. 2D-F;
Movies 1-4). In addition, ATG2 morphants showed atypical
touch-evoked startle response compared with MOspATG1- or
COMOspATG2-injected larvae. The zebrafish larval startle response
triggered by a tactile stimulus may be fragmented into a series of
stereotypic movement patterns, including a high-speed turn, called
the C-bend, which occurs milliseconds after the stimulus and is
required for escape (McClenahan et al., 2012). ATG2 morphants
were unable to initiate a rapid C-bend movement in response to touch
and reproducibly swam straight ahead over short distances compared
with MOspATG1-, COMOspATG1- and COMOspATG2-injected larvae
that showed a C-bend maximal body curvature to escape in the
opposite direction from the stimulus (arrowheads, Fig. 2G,H). These
distinct locomotion behaviours of ATG1 and ATG2 morphants
suggested that the lack of DrM1 or DrM61 could differentially alter
motor circuit formation.
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Fig. 1. Two main spastin isoforms are synthesized during zebrafish development through alternative use of two initiation codons. (A) Alignment of
spastin cDNA sequences surrounding the first and second ATG (bold) from different vertebrate species. Kozak sequences surrounding the first and
second ATG are boxed in red and blue, respectively. Asterisks indicate conserved nucleotides. (B) Schematic representation of the different spastin
constructs used in the present study. Crosses indicate mutated ATG. (C-E) Zebrafish spastin transcript drives the synthesis of two main spastin isoforms
through alternative translation start sites. (C) Western blot analysis of spastin expression in COS-7 cells transfected or not (not transfected, NT) with the
different spastin constructs (see B) using HA and spastin86-340 antibodies. (D) Both zebrafish spastin isoforms display amicrotubule-severing activity in vitro.
Immunolabelling of spastin and microtubules in COS-7 cells overexpressing DrM1 or DrM61-HA using HA (red) and tyrosinated tubulin (green) antibodies.
Dotted lines surround transfected cells. Both overexpressed DrM1 and DrM61 dismantle the microtubule network. Scale bar: 20 µm. (E) Western blot
analysis of exogenous spastin expression from protein extracts of tailbud embryos injected or not with in vitro transcribed mRNAs from the different
spastin constructs using HA antibody. (F) The expression ratio between spastin isoforms varies during zebrafish development. Western blot analysis of
spastin main isoforms during zebrafish development, using spastin86-340 antibody. Protein extracts from tailbud embryos injected with spastin-HA mRNA
and revealed using an HA antibody, were used as DrM1 and DrM61 benchmark. (G) Spastin exon 4 is alternatively spliced during zebrafish development.
RT-PCR analysis of spastin transcripts at both the tailbud stage and 24 hpf using primers flanking the exon 4 of the zebrafish spastin gene. (H,I) Distinct
subcellular distribution of spastin main isoforms in spinal motor neurons in vivo. (H) Immunolabelling of 28 hpf Tg(mnGFF7;UAS:DrM1-HA) and
Tg(mnGFF7;UAS:DrM61-HA) transgenic embryos with an HA antibody. Arrows indicate the punctate distribution of DrM1-spastin along the axon shaft
while empty arrowheads indicate its specific enrichment in spinal motor growth cones. Scale bars: 10 µm. (I) Mean fluorescence intensity profile of DrM1 and
DrM61 staining along the distal part of SMN axons (n=6 and n=8, respectively).
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Spinal motor axon pathfinding is distinctively altered
between the two spastin isoform morphants
Owing to morphant locomotion phenotypes, we analysed spinal
motor neuron (SMN) development in ATG1 and ATG2 morphant
larvae with a special focus on secondary motor neurons (sMN),
which are key players in larval fast swimming and startle response
behaviours. Immunolabelling of 72 hpf ATG1 or ATG2 morphant
Tg(Hb9:GFP) transgenic larvae (Flanagan-Steet et al., 2005)
revealed robust sMN migratory and/or axon pathfinding defects
that were mainly specific to each morphant class. In ATG1
morphants, the rostral nerve appeared misguided in 39% of
spinal hemisegments and abnormally grew caudally along the
Fig. 2. The knockdown of each spastin
isoform differentially alters larval
locomotion. (A) The knockdown of spastin
main isoforms using a morpholino-based
strategy. MOspATG1 and MOspATG2
morpholinos were designed to block spastin
synthesis from the first (M1) or the second
(M61) ATG. (B) Western blot analysis showing
the efficiency of spastin isoform knockdown.
Spastin expression was analysed in protein
extracts from tailbud embryos injected with
MOspATG1, MOspATG2 or their corresponding
control morpholinos using an HA antibody. H2b
was used as a loading control.
(C) Quantification of DrM1 and DrM61 band
density normalised to H2b values (A.U.,
arbitrary units), from four independent
experiments. *P≤0.05. Non-parametric Mann–
Whitney test. Error bars are s.e.m. (D) Overall
morphology (upper panels) and locomotor
behaviour (bottom panels) of 72 hpf larvae
injected with MOspATG1 (n=301), MOspATG2
(n=182) or control morpholinos (COMOspATG1,
n=199 and COMOspATG2, n=194). Upper
panels: Arrow indicates the curved-tail
phenotype of ATG1 morphants. Asterisk and
arrowhead show smaller eyes and yolk tube
agenesis in ATG2 morphants. Bottom panels:
Tracking analysis of 72 hpf control and
morphant larvae in a touch-escape response
test. Each line represents the trajectory of one
larva after touch stimulation, while the dotted
circle radius symbolizes the mean swimming
distance covered by all larvae. Scale bars:
2 mm. (E) Quantification of the mean swimming
distance. (F) Quantification of the mean
swimming speed. (G,H) Touch-evoked startle
response of 72 hpf COMOspATG1 (n=25),
COMOspATG2 (n=24), MOspATG1 (n=48) and
MOspATG2 (n=46) larvae. (G) Representative
time series of control and spastin morphant
larvae responding to a tactile stimulation. White
arrowheads indicate the characteristic high
body curvature (called C-bend) occurring after
the touch stimulation. ATG2 morphants are
unable to make the C-bend movement.
Scale bar: 2 mm. (H) Maximal C-bend body
curvature angle of the startle responses.
(E,F,H) **P≤0.01, ***P≤0.001 versus control
larvae; #P≤0.05, ###P≤0.001 versus ATG1
morphants; Kruskal–Wallis ANOVA test with
Dunn’s post test. Error bars are s.e.m.
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horizontal myoseptum (arrowhead, Fig. 3A,B), a phenotype
rarely observed in COMOspATG1- (0.4%) or MOspATG2- (5.9%)
injected larvae (Fig. 3A,B). In contrast, the rostral nerve of ATG2
morphants failed to form in 49.9% of spinal hemisegments
(empty arrowhead, Fig. 3A,C) compared with MOspATG1
morphant (18%) or COMOspATG2 control larvae (1.1%;
Fig. 3A,C). Furthermore, the dorsal nerve was thinner or absent
in the majority of the hemisegments in both ATG1 (57%)
and ATG2 (96%) morphants compared with controls (asterisk;
COMOspATG1: 0%; COMOspATG2: 3%; Fig. 3A,D). In vivo
time-lapse videomicroscopy showed that sMN axons of ATG1
and ATG2 morphants displayed different navigational behaviours
at the horizontal myoseptum (i.e. choice point), which contrasted
with the highly stereotyped behaviour of control sMN axons
(Fig. 3F; Movies 5-7). As they reached this key intermediate
target, a contingent of sMN axons contributing to the rostral nerve
turned in the opposite direction and grew caudal to the lateral
myosepta (arrowheads, Fig. 3F) in ATG1 morphants, whereas
these rostrally projecting sMN axons abnormally grew ventrally
beyond this choice point to ultimately fasciculate with the ventral
nerve in ATG2 morphants (empty arrowheads, Fig. 3F;
Movies 5-7). Notably, these axon pathfinding defects of both
spastin morphants were not associated with striking muscle fibre
alterations (Fig. S2). Finally, a fraction of ATG2 morphant sMN
somata ectopically exited from the spinal cord and migrated along
the motor tracts into the periphery, which was never observed in
MOspATG1- or COMOspATG2-injected larvae (arrows, Fig. 3A,E,F;
Movies 5-7). Altogether, these different sMN phenotypes of
ATG1 and ATG2 morphants highlight the functional specificity of
each spastin isoform in motor circuit wiring.
DrM1 and DrM61 have crucial and non-overlapping functions
in motor neuron development and zebrafish locomotion
To clarify the functional specificity and redundancy of spastin
main isoforms, and to confirm the relevance of both morphant
phenotypes, we performed rescue and cross-rescue experiments.
Human spastin transcripts (including their 5′UTR) mutated on the
first (M87 mRNAs) or second ATG (M1 mRNAs) were co-injected
with MOspATG1 or MOspATG2morpholinos (Fig. 4). As anticipated,
the overexpression of human M87 rescued the morphological,
locomotion and sMN defects of ATG2 morphants, whereas human
M1 failed to alleviate ATG2 morphant phenotypes (Fig. 4A,C-G).
Fig. 3. ATG1 and ATG2 morphants exhibit
different spinal motor neuron defects.
(A) Immunolabelling of secondary motor neurons
(sMN) in 72 hpf COMOspATG1 (n=29), COMOspATG2
(n=29), MOspATG1 (n=41) and MOspATG2 (n=32)
Tg(Hb9:GFP) transgenic larvae using zn-5 antibody.
Lateral views of the trunk, anterior towards the left.
Dotted lines indicate the horizontal myoseptum
(i.e. axon guidance choice point). White arrowheads
indicate misguided rostral nerves of ATG1
morphants while arrows indicate the ectopic sorting
of sMN somata from the spinal cord of ATG2
morphants. Empty arrowheads and asterisks
indicate missing rostral and dorsal nerves,
respectively. Scale bar: 50 µm. (B-E) Quantification
of sMN defects in 72 hpf control and spastin
morphant larvae (24 spinal hemisegments were
analysed per larva). *P≤0.05, ***P≤ 0.001; Kruskal–
Wallis ANOVA test with Dunn’s post test. The
number (n) of larvae analysed per condition is
indicated under the corresponding histogram bar.
Error bars are s.e.m. (F) Distinctive navigational
behaviour of ATG1 and ATG2 morphant sMN axons
at the choice point. Representative stills of time-lapse
recordings of sMN axon outgrowth monitored in 32
spinal hemisegments of 40-72 hpf Tg(Hb9:GFP)
transgenic larvae injected with MOspATG1,
MOspATG2 or a control morpholino (MOscr).
White arrowheads indicate the aberrant caudal
turning of ATG1 morphant sMN rostral axons at the
horizontal myoseptum (dotted line) while empty
arrowheads indicate the erroneous ventral growth of
ATG2 morphant sMN axons beyond this choice
point. Arrows track the aberrant migration of sMN
somata along motor tracts of ATG2 morphants.
Scale bar: 50 µm.
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Fig. 4. Spastin main isoforms have non-overlapping functions in spinal motor neuron development and locomotor behaviour. (A-G) Rescue
experiments of ATG2morphant phenotypes by M1, M1K or M87 mRNAs. (B) Western blot analysis (bottom panel) of exogenous spastin expression using an HA
antibody in wild-type embryos injected with human spastin (SPG4) mRNAs used for rescue experiments and schematized in the upper panel. The Kozak
sequence surrounding the first ATG of M1 transcript has been replaced by an optimal consensus sequence (M1K mRNA) to boost M1 expression. Actin was
used as a loading control. (H-L) Rescue experiments of ATG1 morphant phenotypes by M1, M1K or M87 mRNAs. (A,H; upper panels) Immunolabelling of
secondary motor neurons (sMN) in 72 hpf control, morphant and ‘rescued’ (i.e. co-injected with MOspATG1 or MOspATG2 together with each version of
human spastin mRNAs) Tg(Hb9:GFP) larvae using zn-5 and GFP antibodies. (A) Arrows, empty arrowheads and asterisks indicate mispositioned sMN,
missing rostral and dorsal nerves, respectively. (H) White arrowheads indicate misguided rostral nerves. Scale bars: 50 µm. (A,H; middle panels) Overall
morphology of 72 hpf control, morphant and ‘rescued’ larvae. (A) Arrowheads indicate yolk tube agenesis and asterisks indicate smaller eyes. (H) Arrows
indicate curved tails. Scale bars: 1 mm. (A,H; bottom panels) Tracking analysis of 72 hpf control, morphants and ‘rescued’ larvae in a touch-escape response test.
Each line shows the trajectory of one larva after the stimulus. Dotted circle radius symbolizes the mean swimming covered distance. Scale bars: 1 mm.
(C-G,I-L) Quantification of sMN defects (24 spinal hemisegments per larva; C-E,I,J), mean swimming distances covered (F,K) and speed (G,L) of 72-hpf
control, morphant and ‘rescued’ larvae. The n value for each larval group is indicated under the corresponding histogram bar. *P≤0.05, **P≤0.01, ***P≤0.001
versus control larvae; ##P≤0.01, ###P≤0.001 versus morphants; Kruskal–Wallis ANOVA test with Dunn’s post test. Error bars are s.e.m.
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To assess whether this inability of M1 to rescue the ATG2morphant
phenotype was due to intrinsically inefficient translation from
the ATG1 codon with respect to ATG2, we replaced the weak
consensus Kozak sequence surrounding the ATG1 codon of
human spastin cDNA by a robust consensus sequence (M1K
mRNA), which increased the expression of M1 up to that of
M87 (Fig. 4B). Nevertheless, higher levels of exogenous M1
still failed to rescue ATG2 morphant defects (Fig. 4A,C-G).
Reciprocally, only human M1 rescued the morphological,
behavioural and sMN defects of ATG1 morphants, even at low
expression levels (Fig. 4H-L). These results ascertained the
specificity of each spastin morphant phenotype and unveiled a
specific role for the main spastin isoforms in vertebrate motor
circuit wiring and locomotion.
Spastin CRISPR/Cas9 mutants develop similar locomotor
and SMN defects as ATG1 and ATG2 morphant larvae
To further strengthen the specificity of the phenotypes associated
with the use of MOspATG1 or MOspATG2morpholinos, we generated
a spastin CRISPR/Cas9 genetic mutant harbouring a truncating
mutation after the second ATG codon (C68X; Fig. 5A-B), thereby
impeding the synthesis of both M1 and M61 spastin isoforms.
The vast majority of spC68X/C68X homozygous mutants appeared
smaller than their control siblings (Fig. 5C) and showed reduced
swimming speed in a touch-escape response test (Fig. 5D-F;
Movies 8, 9) as ATG1 and ATG2 morphant larvae (Fig. 2F).
Furthermore, both spC68X/+ and spC68X/C68X mutants exhibited
pathfinding defects of sMN axons, consisting of a combination of
the axon-targeting errors described in ATG1 (i.e. abnormal caudal
turning of the rostral nerve; white arrowheads, Fig. 5G) and ATG2
(missing rostral and dorsal nerves; empty arrowheads and asterisks,
respectively, Fig. 5G) morphants, and which were more severe in
homozygous than in heterozygous mutants (Fig. 5H-K). However,
the penetrance of these axon pathfinding defects was incomplete
in both spC68X/+ and spC68X/C68X mutants (Fig. 5K). Furthermore,
crossing spC68X/C68Xmutants with Tg(Hb9:GFP) fish led tomisrouted
SMN somata outside the spinal cord in 8.2% of the progeny
(a phenotype also observed in ATG2 morphants) compared with
0% in the crosses between wild-type and Tg(Hb9:GFP) fish
(arrows, Fig. 5L,M). The strong similarities between ATG1, ATG2
morphant and spC68X mutant phenotypes, as well as the dose-
sensitivity of SMN development to spastin expression levels
largely exclude the possibility that the observed defects could be
caused by non-specific effects of morpholino injection or Cas9
genome engineering rather than by the loss of spastin function,
thereby validating both loss-of-function approaches.
DrM1 controls sMN axon targeting by inhibiting the
BMP pathway
M1 spastin was shown to interact with the HSP-causing protein
atlastin 1 (Evans et al., 2006; Sanderson et al., 2006), which
controls zebrafish SMN axon pathfinding through the inhibition
of the BMP pathway (Fassier et al., 2010). Furthermore, atlastin 1
binds to the HSP protein NIPA1 (Rainier et al., 2003; Botzolakis
et al., 2011), which was equally identified as a BMP inhibitor
(Wang et al., 2007; Tsang et al., 2009). To investigate whether
defective BMP signalling could underlie the characteristic
pathfinding defect of the rostral nerve in ATG1 morphants, we
first analysed sMN development in 72 hpf larvae injected with
morpholinos targeting the translation initiation site of either the
atlastin 1 (atl1) (Fassier et al., 2010) or nipa1 transcripts, or with
a universal control morpholino (MOscr). Interestingly, the
knockdown of each of these BMP inhibitors similarly altered
the pathfinding of the rostral nerve, which abnormally grew
caudally along the horizontal myoseptum as described for ATG1
spastin morphants (arrowheads, Fig. 6A,B). Furthermore, the co-
injection of MOatl and MOspATG1 at subefficient doses, which
did not affect sMN development when injected separately,
increased massively the number of misguided rostral nerves
(40%) compared with the co-injection of MOatl and MOspATG2
(5%) (arrowheads, Fig. 6C,D), suggesting that the sMN defects
caused by the lack of DrM1 spastin and atlastin 1 may involve
interference with a common mechanistic pathway. To determine
whether an upregulation of the BMP pathway, independently of
any variation in HSP protein expression, was sufficient to induce
the aberrant caudal turning of the rostral nerve, we generated a
novel Tg(UAS:CA-BMPRI-HA) transgenic line expressing a
constitutively active version of type Ia BMP receptor under
the control of a UAS promoter, based on a published line
(Quillien et al., 2011). To temporally control the upregulation
of BMP signalling, we crossed these fish with the Tg(HspGal4-
ACR) line expressing the transactivator GAL4 under the
control of a heat-shock inducible promoter. We then heat-
shocked the progeny at 42 hpf, when sMN axons composing the
rostral nerve reached the horizontal myoseptum and were
subsequently guided towards their appropriate targets. Heat-
shocked Tg(HspGal4-ACR; UAS:CA-BMPRI-HA) transgenic
larvae showed caudally oriented misguided rostral nerves (26%)
compared with both heat-shocked Tg(UAS:CA-BMPRI-HA) and
non-heat-shocked Tg(HspGal4-ACR; UAS:CA-BMPRI-HA)
control larvae (arrowheads, Fig. 6E,F). This test revealed that
the over-activation of BMP signalling altered sMN axon targeting
in a similar way to the loss of DrM1 spastin, atlastin 1 or NIPA1.
We finally assessed whether a genetic inhibition of the BMP
pathway could alleviate the sMN defects of spastin ATG1 or
nipa1 morphants as previously shown for atl1 knockdown
(Fassier et al., 2010). To this aim, MOspATG1, COMOspATG1,
MOnipa1 and MOatl morpholinos were injected in Tg(Hsp70:
DN-BMPR1-GFP) transgenic embryos expressing a dominant-
negative version of type-Ia BMP receptor under the control of a
heatshock-inducible promoter (Pyati et al., 2005). ATG1, nipa1
and atl1 morphant Tg(Hsp70:DN-BMPR1-GFP) larvae, which
were subjected to heat shock at 42 hpf, showed a striking
reduction in the number of mistargeted rostral nerves at
72 hpf compared with non-heat-shocked morphant siblings or
heat-shocked control larvae (44%, 83.7% and 89% reduction,
respectively; Fig. 6G-H). In contrast, the inhibition of BMP
signalling had no beneficial impact on ATG2 morphant sMN
phenotypes (Fig. 6I-K). Altogether, these results showed a
specific role for DrM1 spastin in sMN axon targeting via the
inhibition of the BMP pathway and provide in vivo evidence
for a similar role of the HSP gene nipa1 in vertebrate motor
neuron development.
DrM61 acts downstream of neuropilin 1a signalling in spinal
motor neurons
To unravel the signalling pathway(s) in which spastin short isoform
is involved during SMN development, we focused on the migratory
motor neuron phenotype (i.e. the aberrant exit of SMN cell somata
from the spinal cord), which was exclusively observed in ATG2
morphants. We searched for similar migratory defects in published
mutants or morphants for signalling cues and associated receptors
known to be involved in neuronal migration and axon guidance
processes. Notably, the knockdown of the semaphorin receptor
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Fig. 5. Spastin CRISPR/Cas9 mutants show overlapping locomotor and SMN phenotypes with ATG1 and ATG2 morphants. (A) mRNA and protein
sequences of wild-type (WT) and spC68X CRISPR/Cas9 mutant (Mut). The second ATG codon (Met 61) and premature stop codons (*) are indicated in red
and green, respectively. Black and blue letters are used to discriminate two successive codons. Numbers indicate amino acid position. (B) Sequence analysis
of wild-type (sp+/+) and spC68X/C68X mutant DNA. Red dashed boxes show the nucleotide substitution generating a premature STOP codon. (C) Overall
morphology of 72 hpf sp+/+ and spC68X/C68X larvae. Scale bar: 6 mm. Some mutant larvae are smaller than their control siblings. (D-F) Touch-evoked escape
behaviour of 72 hpf larvae obtained from crosses between spC68X/C68X and spC68X/+ or control sp+/+. (D) Each line represents the trajectory of one larva after
touch stimulation. Dotted-circle radius symbolises the mean swimming distance covered by all larvae. The distance between two dots represents the
distance covered by a larva between two consecutive frames. Scale bar: 4 mm. (E,F) Quantification of the mean swimming distance (E) and mean
swimming speed (F). (G) Immunolabelling of sMN in sp+/+, spC68X/+ and spC68X/C68X larvae using zn-5 antibody. Arrows indicate control rostral nerves, while
white arrowheads, empty arrowheads and asterisks indicate misguided rostral nerve, missing rostral nerves and dorsal nerves of spC68X mutant larvae,
respectively. (H-J) Quantification of sMN defects in 72 hpf sp+/+, spC68X/+ and spC68X/C68X larvae. Quantifications were carried out on 24 spinal hemisegments
per larva. (K) Penetrance of SMN defects. (L) Immunolabelling of SMN in 72 hpf sp+/+ or spC68X/+ Tg(Hb9:GFP) larvae using a GFP antibody. Arrows indicate
mispositioned SMN somata. (M) Percentage of larvae with ectopic sorting of SMN somata outside the spinal cord. (E,F,H-K,M) The number (n) of larvae
analysed per condition is indicated under the corresponding histogram bar. *P≤0.05, ***P≤0.001 versus internal controls; #P≤0.05, ##P≤0.01 versus spC68X/+
larvae; non-parametric Mann–Whitney test (E,F); Kruskal–Wallis ANOVA test with Dunn’s post test (H-J) and χ2 test (K). Error bars are s.e.m. (G,L) Lateral views
of the trunk, anterior towards the left. Scale bars: 50 µm.
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Fig. 6. DrM1 controls secondarymotor axon targeting throughBMP inhibition as atlastin 1 and NIPA1 do. (A,C,E,G,I) Immunolabelling of secondary motor
neurons (sMN) at 72 hpf using zn-5 (A,G), zn-5 and HA (E), or zn-5 and GFP antibodies (C,I). Lateral views of the trunk, anterior towards the left. White
arrowheads, empty arrowheads and arrows indicate misguided rostral nerves, missing rostral nerves and misplaced SMN somata, respectively. (B,D,F,H) Mean
percentage of misguided rostral nerves. (J) Mean percentage of hemisegments without rostral nerves. (K) Mean number of misplaced SMN somata per embryo.
(B,D,F,H,J,K) Quantifications were performed on 24 spinal hemisegments per larva. The n value for each larval group is indicated under the corresponding
histogram bar. **P≤0.01, ***P≤0.001 versus internal controls; $$$P≤0.001 for co-injection comparison; #P≤0.05, ##P≤0.01, ###P≤0.001 versus morphant larvae;
Kruskal–Wallis ANOVA test with Dunn’s post test. Error bars are s.e.m. (A,B) sMN analysis in larvae injected with MOspATG1, MOatl, MOnipa1 or control (MOscr)
morpholinos. (C,D) sMN analysis in larvae injected with sub-efficient doses of MOspATG1, MOspATG2 or MOatl morpholinos or co-injected with the same
sub-efficient doses of MOatl and MOspATG1 or MOspATG2 morpholinos. (E,F) sMN analysis in non-heat-shocked or heat-shocked Tg(HspGal4-ACR;UAS:
CA-BMPRI-HA) and heat-shocked Tg(HspGal4-ACR) transgenic larvae. (G-K) sMN analysis in non-heat-shocked or heat-shocked Tg(Hsp70:DN-BMPR1-GFP)
transgenic larvae injected with MOspATG1, MOatl, MOnipa1, MOspATG2 and appropriate control morpholinos. Scale bars: 50 µm.
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neuropilin 1a (Nrp1a) was shown to cause the misrouting of
SMN cell somata from the spinal cord into the periphery (Feldner
et al., 2005). Immunolabelling and time-lapse videomicroscopy of
Tg(Hb9:GFP) transgenic larvae injected with nrp1a morpholino
(MOnrp1a; Feldner et al., 2005) confirmed that Nrp1a-depleted
SMN somata abnormally migrated into the periphery along spinal
motor tracts (arrows, Fig. 7A-C; Movie 10), as shown for ATG2
morphant SMNs (Fig. 3F; Movie 7). Co-injection of mouse Nrp1
mRNA together with a zebrafish nrp1a morpholino rescues both the
morphological and SMN migratory defects of nrp1a morphants,
reinforcing the specificity of these phenotypes (Fig. 7D-F).
Moreover, the double knockdown of Nrp1a and DrM61 spastin
isoform using sub-efficient doses of MOnrp1a and MOspATG2
morpholinos dramatically increased the number of mispositioned
SMN somata, compared with the co-injection of MOnrp1a
and MOspATG1 or to the single injection of each morpholino
(Fig. 7G-H). To determine whether DrM61 spastin could act
downstream of the Nrp1a receptor, we carried out rescue
experiments by overexpressing DrM61 spastin, either
ubiquitously or selectively in SMNs, in an nrp1a morphant
context. To achieve this, nrp1a morpholino (MOnrp1a) was
co-injected with DrM61spastin-HA mRNA (Fig. 7I,K) in
Tg(Hb9:GFP) embryos or injected in triple transgenic Tg(mnGFF7;
UAS:GFP;UAS:DrM61-HA) embryos specifically expressingDrM61
spastin and GFP in SMNs (Fig. 7J,L-M). Importantly, both the
ubiquitous and SMN-targeted overexpression of DrM61 spastin
partially rescued the aberrant exit of nrp1amorphant SMN somata
from the spinal cord. In contrast, the overexpression of DrM1 in
the nrp1amorphant background failed to alleviate these migratory
defects (Fig. 7I,K). Furthermore, although 74% of ectopic
SMN somata in MOnrp1a-injected Tg(mnGFF7; UAS:GFP;
UAS:DrM1-HA) larvae were HA positive, this rate dropped to 11%
in MOnrp1a-injected Tg(mnGFF7; UAS:GFP; UAS:DrM61-HA)
larvae (empty arrowheads; Fig. 7J,L-M). This suggested that most
neurons that failed to be rescued by DrM61-HA did not express the
rescuing transgene, which might be due to the intrinsic variegation
in transgene expression, frequently occurring in transgenic zebrafish.
These data thus unveiled a specific role for DrM61 as a downstream
effector of Nrp1a signalling in spinal motor neurons.
DISCUSSION
This in vivo functional analysis of the main spastin isoforms reveals
their crucial and specific involvement in two distinct developmental
signalling pathways that are both essential for motor circuit wiring
and locomotion in vertebrates. Here, we provide evidence for a
concerted role for DrM1 spastin and the HSP-causing proteins
atlastin 1 and NIPA1 in the inhibition of the BMP pathway and
unveil a specific role for DrM61 spastin as a downstream effector of
neuropilin 1a signalling in developing motor neurons.
Multiplying spastin function through alternative translation
We and others have previously shown that the dysregulation of
microtubule (MT) dynamics associated with the lack of spastin
MT-severing activity is crucial for motor axon development and/or
homeostasis in invertebrate and vertebrate model organisms
(Sherwood et al., 2004; Trotta et al., 2004; Tarrade et al., 2006;
Wood et al., 2006; Fassier et al., 2013; Denton et al., 2014; Havlicek
et al., 2014; Brill et al., 2016). However, owing to the growing
interest in this major HSP protein, the characterisation of its
function in various cellular processes has progressively added
to the richness of its functional diversity but simultaneously
complicated the comprehensive understanding of SPG4-linked
HSP physiopathology. Indeed, the main spastin isoforms have so far
been involved in many cellular processes, including ER shaping
(M1; Park et al., 2010), lipid droplet homeostasis (M1; Papadopoulos
et al., 2015) and endosomal tubule fission (M1 and M87; Allison
et al., 2013, 2017), although the causal connection between their
dysfunction and HSP axonopathy remains to be determined. A major
challenge in the field therefore aims to decipher the individual
function(s) of each spastin isoform and to identify the HSP-causing
culprit(s) among them. To tackle this key issue, we undertook the first
comparative loss-of-function analysis of spastin main isoforms
in vivo, using a morpholino-based strategy to block their respective
synthesis from each initiation codon during zebrafish development.
Our study provides a proof of concept that morpholino-based
knockdown analyses coupled with appropriate rescue experiments
and relevant controls (Stainier et al., 2017), including a newly
generated spC68X mutant, represent an appropriate approach to
block the expression of protein isoforms resulting from alternative
translation, unlike conventional si- or sh-RNA gene silencing
technologies that mostly trigger the degradation of the targeted
transcript (Summerton, 1999). This strategy allowed us to unmask
a crucial and specific role for each spastin isoform in motor circuit
wiring and larval locomotion. Although M1 has previously been
shown to carry out selective cellular functions through its exclusive
transmembrane hairpin domain (Park et al., 2010; Papadopoulos
et al., 2015), we here identify a specific role for the N-terminally
truncated isoform DrM61 in zebrafish SMN migration and axon
targeting, which is supported by: (1) its contrasted subcellular
distribution with respect to DrM1; (2) the marked differences
in SMN and behavioural defects between ATG1 and ATG2
morphants; and (3) the inability of M1 to rescue the phenotypes of
ATG2 morphants. Furthermore, M1 has so far been suggested to
play a major role in HSP pathogenesis (Solowska et al., 2008,
2014; Leo et al., 2017). However, our loss-of-function analysis,
mimicking the haploinsufficiency associatedwith the vast majority of
SPG4 mutations (Fonknechten et al., 2000; Roll-Mecak and Vale,
2008; Riano et al., 2009), establishes that the depletion of DrM61,
independent of any impact on DrM1, is at least as detrimental for
developing motor neurons as the depletion of DrM1. Altogether,
our data thus demonstrate that alternative translation of the SPG4
transcript and the partly resulting multifunctionality of spastin are
required for vertebrate motor circuit wiring. These results also
suggest that the haploinsufficiency of each spastin isoform may
concomitantly alter motor circuit formation and connectivity
through distinct pathogenic pathways.
DrM61 acts downstream of neuropilin 1a signalling
Our analysis of DrM61 during zebrafish development identifies a
specific role for this short isoform as a downstream effector of the
neuropilin 1a (Nrp1a) receptor in motor neurons. DrM61 is required
for Nrp1a-mediated inhibition of SMN somata migration outside the
zebrafish spinal cord, a cellular process involving both semaphorin
3A and VEGF ligands (Feldner et al., 2005). Importantly, the
signalling pathways induced by the interactions between these cues
and the Nrp1 receptor have been involved in mammalian motor
circuit development and maintenance, such as motor neuron somata
migration (Schwarz et al., 2004; Lee et al., 2015), axon pathfinding
and fasciculation (Jouet et al., 1994; Castellani et al., 2000; Huber
et al., 2005; Huettl et al., 2011), and motor neuron survival
(Oosthuyse et al., 2001). Furthermore, they recently emerged as
key pathogenic pathways in two other neurodegenerative disorders
affecting upper and/or lower motor neurons (Venkova et al., 2014;
He et al., 2015). Altogether, these data may therefore imply that
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defective Nrp1 signalling associated with M87 deficiency may
contribute to SPG4-linked HSP by altering upper motor tract
development and/or homeostasis. How would M87 regulate
Nrp1-mediated pathways? As M87 exhibits an increased severing
activity compared with M1 (Solowska et al., 2008), one possible
explanation could be that M87 participates in the remodelling of
Fig. 7. See next page for legend.
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the microtubule cytoskeleton required for Nrp1-mediated motor
neuron migration and/or axon targeting. However, as M87 spastin
was shown to be sufficient to rescue the endosomal tubulation
phenotype of cells lacking spastin (Allison et al., 2013), a role for
this short isoform in Nrp1 endosomal trafficking could also been
considered. Further investigations will thus be required to clarify the
molecular mechanisms underlying M87 functional specificity.
DrM1 is a BMP inhibitor
Over the past decades, several studies in invertebrate models
revealed the key regulatory role of the BMPs in motor axon
guidance (Colavita et al., 1998) and synapse formation at the
neuromuscular junction (Bayat et al., 2011). Furthermore, the over-
activation of BMP signalling has progressively emerged as a
common pathogenic mechanism in five genetic subtypes of
HSP (Wang et al., 2007; Fassier et al., 2010; Renvoisé et al.,
2012; Nahm et al., 2013; Song et al., 2013; Mao et al., 2015). This
dual involvement of BMP signalling in both motor neuron
development and degeneration raised new issues on the timing of
the initial pathogenic defects causing HSP. Notably, defective BMP
signalling was suggested to contribute to SPG4-linked HSP based
on the increased phosphorylation of its canonical readout Smad1/5,
which was associated with spastin knockdown in HeLa cells (Tsang
et al., 2009). We here confirmed these in vitro findings by
unravelling a specific role for M1 as a BMP inhibitor required for
vertebrate motor circuit wiring. DrM1 morphants or spC68Xmutants
exhibit SMN axon pathfinding defects that strikingly mimic those
associated with: (1) the depletion of HSP-causing BMP inhibitors
atlastin 1 and NIPA1; or (2) the overexpression of a constitutively
active version of BMPRI; and (3) are partially rescued by the genetic
inhibition of BMP signalling. Moreover, our work revealed a
cooperative role for two key AD-HSP partners, atlastin 1 and spastin,
in the inhibition of the BMP pathway, which further supports the
key role of BMP signalling in HSP physiopathology. How would
M1 spastin participate in the regulation of this pathway? NIPA1
and atlastin 1 have been shown to modulate BMP signalling
through the regulation of BMP receptor trafficking (Wang et al.,
2007; Tsang et al., 2009; Nahm et al., 2013; Zhao and Hedera,
2013). Furthermore, both spastin-depleted HeLa cells and motor
neuron growth cones of ATG1 morphants exhibit abnormal
endosomal tubulation, which was associated with defective
trafficking of transferrin receptors in the mammalian cells
(Allison et al., 2013). Therefore, M1 most likely acts in concert
with these HSP proteins to control BMP receptor trafficking and
plasma membrane concentration, which may in turn influence motor
neuron responses to extracellular BMP signals. Interestingly, BMP
signalling has been shown to regulate MT stability and axonal
transport homeostasis in Drosophila motor neurons (Wang et al.,
2007; Nahmet al., 2013), two crucial processes in spastin-related HSP
pathogenesis (Tarrade et al., 2006; Fassier et al., 2013; Denton et al.,
2014; Havlicek et al., 2014).
In conclusion, the functional analyses of genes responsible
for neurodegenerative disorders have gradually unveiled crucial
molecular links between neurodegenerative processes and key
developmental signalling pathways mediated by axon guidance
molecules (Bai et al., 2011; Van Hoecke et al., 2012; Venkova
et al., 2014; He et al., 2015). Although their role as neuronal
circuit wirers has been well established, the dissection of their
contribution to neurodegenerative diseases represents an important
area for future research in the field, which would provide priceless
information on their potential use as tractable therapeutic targets.
MATERIALS AND METHODS
Zebrafish care and maintenance
Zebrafish embryos (Danio rerio) were obtained from natural spawning
of wild-type or transgenic Tg(Hb9:GFP) (Flanagan-Steet et al., 2005),
Tg(mnGFF7;UAS:GFP) (Asakawa et al., 2008, 2013), Tg(Hsp70:DN-
BMPR1-GFP) (Pyati et al., 2005), Tg (HuC:Gal4; UAS:myr-Venus)
(Baraban et al., 2013), the newly generated Tg(UAS:DrM1-Spastin-HA),
Tg(UAS:DrM61-Spastin-HA), Tg(UAS:CA-BMPRI-HA) derived from the
published line (Quillien et al., 2011), Tg(HspGal4-ACR), and the spastin
CRISPR/Cas9 spC68X mutant lines. All embryos were maintained at 28°C
in E3 medium and staged by hour post-fertilisation (hpf ) and gross
morphology according to Kimmel et al. (1995). Pigment formation was
prevented by adding 0.2 mMof 1-phenyl-2-thiourea (PTU, Sigma) to the E3
media after the prim-5 stage. To induce transgene expression from hsp
promoters, larvae were heat-shocked for 60 min at 40°C in pre-warmed E3
medium using a thermomixer (Eppendorf ).
All our experiments were performed in agreement with the European
Directive 210/63/EU on the protection of animals used for scientific
purposes, and the French application decree ‘Décret 2013-118’. The fish
facility has been approved by the French ‘Service for animal protection and
health’, with the approval number A-75-05-25.
Constructs and generation of transgenic and mutant lines
Zebrafish spastin cDNA was obtained from the IMAGE clone 4725923,
including 121 bases upstream of theATG initiation codon. It was subsequently
amplified andHA-tagged by PCR and cloned into pCS2+ using the XhoI/XbaI
restriction sites (pCS2+DrSp-HA). Targeted mutagenesis of the first ATGwas
performed using the megaprimer PCR method (pCS2+DrSp-HAMutATG1)
while the mutagenesis of the second ATG codon was carried out using the
QuickChange site-directed mutagenesis kit (Stratagene) and a set of
complementary primers (pCS2+DrSp-HAMutATG2).
The DNA constructs used to generate the Tg(UAS:DrM1-HA) and
Tg(UAS:DrM61-HA) transgenic lines were composed by assembling the
three elements below in the following order: (1) a SacII-SwaI fragment of
Fig. 7. DrM61 acts as a downstream effector of neuropilin 1a signalling in
motor neurons. (A-C) Neuropilin 1a (nrp1a) morphants show misrouted motor
neuron somata similar to ATG2 morphants. (A) Analysis of secondary motor
neurons (sMN) in 72 hpf Tg(Hb9:GFP) transgenic larvae injected with
MOnrp1a, MOspATG2 or MOscr morpholinos using zn-5 and GFP antibodies.
(B) Representative stills of time-lapse recordings showing SMN behaviour in
40-72 hpf Tg(Hb9:GFP) transgenic larvae injected with Nrp1a (n=5 larvae; n=32
spinal hemisegment monitored). Arrows track the aberrant migration of SMN
somata along motor axon tracts of nrp1a morphants. Scale bar: 10 µm. (D-F)
Rescue experiments of nrp1a morphant phenotypes with mouse Nrp1 mRNA
(Ms_nrp1 mRNA). (D) Overall morphology (upper panels) and SMN analysis
(bottom panels) of 72 hpf larvae injectedwithMOscr, MONrp1a or MONrp1a and
Ms_nrp1mRNA. (E) Distribution of wild-type and nrp1amorphant phenotypes in
each injection group. ***P≤0.001; χ2 test. (F) Mean number of misplaced SMN
somata per larvae. (G) SMN analysis in 72 hpf Tg(Hb9:GFP) transgenic larvae
injected with sub-efficient doses of MOspATG1, MOspATG2 or MONrp1a or co-
injected with the same sub-efficient doses of MONrp1a and MOspATG1 or
MOspATG2 morpholinos. (I) SMN analysis in 72 hpf Tg(Hb9:GFP) transgenic
larvae injected with control (MOscr) or MONrp1amorpholinos or co-injected with
MONrp1a and DrM1- or DrM61-spastin mRNA. (J) SMN analysis in 72 hpf
Tg(mnGFF7;UAS:GFP), Tg(mnGFF7;UAS:GFP;UAS:DrM61-HA) and
Tg(mnGFF7; UAS:GFP;UAS:DrM1-HA) transgenic larvae using HA and GFP
antibodies. (A,D,G,I,J) Lateral views of the trunk, anterior towards the left. Arrows
indicate mispositioned SMN somata. Scale bars: 50 µm. (J) Empty arrowheads
indicatemisplacedHA-positive SMN. (C,F,H,K,L)Mean number ofmispositioned
SMN per larva (quantified on 24 spinal hemisegments/larva). (M) Percentage of
misplaced HA-positive or -negative SMN per larva (quantified on 24 spinal
hemisegments/larva). (C,F,H,K-M) The number of larvae or SMN analysed per
group (n) is mentioned under each corresponding histogram bar. *P≤0.05,
**P≤0.01, ***P≤0.001 versus internal controls; $$$P≤0.001 versus single
injection of each morpholino; ###P≤0.001 versus morphant larvae; ††P≤0.01,
†††P≤0.001 HA-positive versus -negative SMN; Kruskal–Wallis ANOVA test with
Dunn’s post test. Error bars are s.e.m.
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plasmid ‘T2 US E1B Cit UAS E1B MCS ACR’ (a kind gift from
Sebastian Gerety and David Wilkinson, Neural Development
Laboratory, The Francis Crick Institute, London, UK) composed of an
‘alpha-crystallin:mRFP’ cassette for screening purposes; (2) a SwaI-AvrII
fragment containing a promoter module made of five UAS sites followed
by a minimal promoter and a short leader sequence (Baraban et al., 2013);
and (3) a SpeI-NotI fragment containing the full-length DrSp-HAMutATG1
or DrSp-HAMutATG2 cDNAs followed by the SV40 3′UTR and
polyadenylation signal of the pCS2+ vector. These resulting constructs
were cloned into pBluescrit SKI-SceI (Grabher et al., 2004) to yield
(UAS:DrM61-HA) and (UAS:DrM1-HA) plasmids, and were injected at
30 pg/egg into freshly fertilised zebrafish eggs together with the I-SceI
endonuclease (Roche). Injected fish were raised to adulthood and screened
for germline transmission by detecting the red fluorescence in the lens of
their progeny at 72 hpf. The Tg(UAS:DrM1-HA) and Tg(UAS:DrM61-HA)
transgenic lines were established from these positive carriers.
For the Tg(UAS:CA-BMPRI-HA) line, the constitutively active form
of BMP type-1a receptor (Nikaido et al., 1999) was PCR-amplified and
HA-tagged from a ‘pME-MCS-ca-BMPR1-HA’ construct (a kind gift
from Elise Cau and Patrick Blader, Centre de Biologie Intégrative,
Université Toulouse III - Paul Sabatier, Toulouse, France; Quillien et al.,
2011) using the following primers: AvrII-zBMPRIa-CA_FOR: 5′-
TACGCGCCTAGGCAATTTGACAATGC- GTCAGC-3′ and NotI-HA-
zBMPRIa-CA_REV: 5′-TTTTCCTTTTGCG-GCCGCTCAAGCGTAATC-
TGGAACATCGTATGGTGAGATTTTAAT- GTCTTGAGATTCC-3′, and
cloned in place of spastin cDNA in the (UAS:DrM61-HA) plasmid using the
AvrII/NotI restriction sites. Transgenic fish were generated and identified as
described above. The Tg(HspGal4-ACR) line was generated in David
Wilkinson’s lab.
Human spastin cDNA mutated on the second ATG (encoding M1) was
obtained from a pIRESspastin-m87 construct provided by E.R.’s lab
(Allison et al., 2013). As this construct had no 5′UTR, which is required for
the regulation of spastin isoform ratio, we amplified a 245 bp fragment
corresponding to human SPG4 5′UTR from human genomic DNA [kindly
provided by Catalina Betancur, Sorbonne Universités, Neuroscience
Paris Seine - Institut de Biologie Paris-Seine (NPS-IBPS), Paris, France].
and cloned it in pIRESspastin-m87 using the EcoRI site located upstream
SPG4 first initiation codon (primers Nhe-AvrII-spastinUTR_FOR:
5′-ATTGCTAGCCTAGGCCCGAGCCACCGACTGCAGG-3′ and Eco-
spastinUTR_REV: 5′-GGCGAATTCATTCACAGCTCTCACTGCC-3′).
M1-spastin cDNA including the 5′UTR was next subcloned in place of the
zebrafish spastin cDNA in the (UAS:DrM61-HA) plasmid using AvrII/NotI
restriction sites to yield the (UAS:M1-HA) construct. In the (UAS:M1K-HA)
construct, the 5′UTR sequence was removed and the initiation codon was
placed immediately after the 5′-ACTTTGAGCTCCTCCACACGAATTGC-
TAGC-3′ Kozak leading sequence, which provides a more favourable
translation initiation context. (UAS:M87-HA) was generated by targeted
mutagenesis of the (UAS:M1-HA) construct using the megaprimer PCR
method. All human spastin constructs were subcloned in the pCS2+ vector
and in vitro transcribed using the SP6 mMessage mMachine kit (Ambion).
The spC68X mutant was generated by TEFOR-AMAGEN (UMS CNRS
3504/INRA 1374). Cas9 protein and sgRNA targeting a region downstream
of the second ATG codon (sgRNA364: 5′-GCCAAAGAGTGCGGCCC-
CGA-3′) were synthesised by Tacgene facility. Wild-type TU embryos
(n=45) were injected at the one-cell stage with 1 nl of a solution containing
19 µM of Cas9 protein and 50 ng/µl of sgRNA364. To test sgRNA
efficiency, genomic DNA was isolated from seven embryos and PCR
amplified with the Dream Taq DNA Polymerase (ThermoFisher Scientific)
using primers flanking the Cas9-targeted region (FOR: 5′-CAAACCAG-
AGAGCCGGACA-3′; REV: 5′-GCTTGTTTGTGGTAGTTTCGGA-3′).
PCR products were analysed by capillary electrophoresis with the
LabChip 1K DNA assay (Perkin Elmer). Under these conditions, 100%
of the embryos injected with the sgRNA364 were mutants. Founders
were then outcrossed with the wild-type TU strain and the resulting F1
embryos were screened for frameshift mutations by PCR (as mentioned
above) and Sanger sequencing. A founder fish harbouring a premature
stop codon at amino acid 68 was selected and outcrossed to wild-type
mates to create the spC68X mutant line. Heterozygous carriers of the
mutant allele (spC68X/+) were then incrossed to generate homozygous
mutant larvae (spC68X/C68X).
Morpholinos and RNA injections
Morpholino oligonucleotides (MO) targeting each translation start site of
zebrafish spastin mRNA and nipa1 mRNA, as well as control mismatch or





GTGCGA-3′; and MOscr, 5′-CCTCTTACCTCAGTTACAATTTATA-3′.
MOs were injected at two-cell stage. MOspATG1, COMOspATG1 and
MOnipa1were injected at 0.4 pmol/embryowhileMOspATG2, COMOspATG2,
MOatl (Fassier et al., 2010), MOnrp1a (Feldner et al., 2005) andMOscr were
injected at 0.2 pmol/embryo. For rescue experiments, mouse Nrp1 cDNA
(Nrp1-201: ENSMUST00000026917.9) was reverse transcribed, PCR
amplified (forward primer, 5′-ATCCGGAATTCATGGAGAGGGGGCTG-
CCGTTGC-3′; reverse primer, 5′-CTAGTCTAGATTAAGCGTAATCTG-
GAACATCGTATGGGTACGCCTCTGAGTAATTACTCTGTGGG-3′) and
HA-tagged using the SuperScript III One-Step RT-PCR System with
Platinum Taq High Fidelity (ThermoFisher Scientific) from a total RNA
extract of E16.5 mouse embryonic brain following the manufacturer’s
instructions. The PCR product was subsequently cloned in the pCS2+ vector
using EcoRI and XbaI restriction sites. Human spastin and mouse Nrp1
mRNAs were in vitro transcribed from linearised pCS2+ constructs using the
SP6 mMessage mMachine kit (Ambion) and injected at the one-cell stage at
200 pg per embryo.
Touch-escape response test and manual tracking
Locomotor behaviour of control, spastin mutant, morphant and rescued
larvae was assessed at 72 hpf by performing a touch-escape response test.
A tactile stimulus was applied on each larva with a pair of forceps and
their escape behaviour was recorded under a Leica M165 C binocular
stereomicroscope equipped with a Leica IC80 HD camera. Swimming speed
and covered distance of each larva were quantified using the Manual
Tracking plug-in (ImageJ software). Stereotypic movement patterns of the
touch-evoked startle response were recorded under a Leica M165 FC
binocular stereomicroscope equipped with a DFC 345 FX camera. C-bend
maximal body curvature angles were manually scored from the videos as
described previously (Jain et al., 2014).
Whole-mount immunohistochemistry
Zebrafish embryos or larvae were fixed in 4% paraformaldehyde for 2 h at
room temperature, washed with PB-T1% (1% Triton X-100 in PBS),
permeabilised in a 0.25% trypsin solution (at 25°C) after 24 hpf,
blocked for 2 h in PB-T1% supplemented with 10% of normal goat
serum and subsequently incubated overnight with the following
antibodies: zn-5 (1:200, ZIRC, University of Oregon), GFP (1:1000,
A11122, Molecular Probes), HA (1:100, 11867423001, Roche), F59
and F310 (1:100, Developmental Studies Hybridoma Bank, F59 and
F310 was deposited to the DSHB by F. E. Stockdale). After several
washes in 1% PBT, larvae were incubated overnight at 4°C with Alexa
Fluor 488- or 555-conjugated goat anti-mouse, -rabbit or -rat
antibodies (1:1000, Molecular Probes). For sMN and muscle fibre
analysis, images were acquired using a fluorescence microscope
equipped with an Apotome module (Zeiss, Axiovert 200M) and a
20× air objective (NA 0.5) and processed with the ImageJ software.
Images of spastin isoform distribution in SMN were acquired using
a confocal laser-scanning microscope (TCS SP5 Acousto-Optical
Beam Splitter; Leica) and a 63× oil immersion objective (NA 1.4).
The fluorescence intensity profile of DrM1 and DrM61 spastin in
SMN axons (n=6 and n=8, respectively) was estimated along a 25 μm
long lane starting from the distal tip of the axon (ImageJ). The
fluorescence intensity background was measured in an adjacent region
of the axon using the same region of interest and was subtracted from
each spastin value before statistical analysis.
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In vivo time-lapse videomicroscopy
MOspATG1, MOspATG2 and MOscr-injected Tg(Hb9:GFP) transgenic
embryos were anesthetised at 40 hpf with tricaine and embedded in
0.8% low melting agarose in a 35 mm glass dish (Iwaki). Time-lapse
videomicroscopy recordings of sMN axon navigation were carried out
using a Leica DMI 6000B inverted spinning-disk microscope with a
40×/1.25 NA immersion objective over a period of 32 h. Z-stacks of 1 µm
were taken over a 70 µm depth every 8 min and compiled into time-lapse
movies or figure panels.
Cell culture, transfection and immunocytochemistry
COS-7 (ATCC CRL1651) cells were cultured in DMEM supplemented
with 10% foetal calf serum at 37°C under 5% CO2. cDNA constructs were
transfected using Lipofectamine 2000 according to the manufacturer’s
instructions (Life Technologies) with a DNA:Lipofectamine ratio of 1:1.5.
Cells were fixed 24 h post-transfection in a 4% PFA/4% sucrose solution for
20 min, blocked in 3% PBS-BSA supplemented with 5% normal goat serum
and incubated with HA (1:100, 11867423001, Roche) and tyrosinated tubulin
(1:4000, T9028, Sigma) antibodies. After several washes in PBS, cells were
incubated with appropriate Alexa Fluor-conjugated secondary antibodies.
Western blot analysis
COS-7 cells and zebrafish embryos were respectively lysed in SDS-lysis
buffer [25 mM sodium phosphate (pH 7.2), 5 mM EDTA, 1% SDS] and
SDS sample buffer [0.5 µl per embryo; 1 M Tris-HCl (pH 6.8)/10%
glycerol/5% β-mercaptoethanol/3.5% SDS], supplemented with a cocktail
of protease inhibitors (Roche). A total of 10 µg of zebrafish protein extracts
and 5 µg of total protein lysates from COS-7 mock and transfected cells were
electrophoresed into 10% SDS-PAGE gel and transferred onto nitrocellulose
membranes. Immunoblottingwas performed after overnight incubation at 4°C
with HA (1:5000, 11867423001, Roche), spastin86-340 (1:1000; Connell
et al., 2009), H2b (1:16,000, ab1790, Abcam) and actin (1:10,000, AC-40,
Sigma) antibodies. Immunostained proteins were visualised using
appropriate peroxydase-labelled antibodies (Jackson ImmunoResearch)
and a chemiluminescence detection system (Santa Cruz Biotechnology).
DrM1 and DrM61 levels were estimated by quantifying blot band density
normalised to H2b values (ImageJ software).
Statistics
All data were obtained from at least three independent experiments and
are presented as mean±s.e.m. The statistical significance of the data was
evaluated using the non-parametric Mann–Whitney test when comparing two
groups (assuming non-Gaussian distribution) or using the Kruskal–Wallis
ANOVA test with Dunn’s post test or the one-way ANOVA test with
Bonferroni’s post-test when analysing more than two groups (assuming non-
Gaussian distribution or Gaussian distribution, respectively). Data distribution
was tested for normality using the D’Agostino and Pearson omnibus
normality test. For rescue experiments of the Nrp1 morphant phenotype,
the statistical significance in the distribution of the morphological phenotypes
observed in the different experimental conditions was evaluated using the χ2
test. All statistical analyses were carried out using GraphPad Prism. P-values
less than 0.05 were considered significant.
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